Smith & Nephew Plc Change in Director Details
February 23 2024 - 2:00AM
RNS Regulatory News
RNS Number : 8090D
Smith & Nephew Plc
23 February 2024
23
February 2024
SMITH & NEPHEW
PLC
Notification under Listing Rule
9.6.14
Anne-Francoise Nesmes, Chief
Financial Officer of Smith & Nephew plc, will join the Board of
Sanofi S.A. as an independent non-executive director with effect
from 30 April 2024, subject to Sanofi shareholder
approval.
Enquiries
Investors
Andrew Swift
Katherine Rycroft
Smith+Nephew
|
+44 (0) 1923 477433
+44 (0) 7811 270734
|
Media
Charles Reynolds
Smith+Nephew
|
+44 (0) 1923 477314
|
Susan Gilchrist / Ayesha Bharmal
Brunswick
|
+44 (0) 20 7404 5959
|
About Smith+Nephew
Smith+Nephew is a portfolio medical
technology business that exists to restore people's bodies and
their self-belief by using technology to take the limits off
living. We call this purpose 'Life Unlimited'. Our 19,000 employees
deliver this mission every day, making a difference to
patients' lives through the excellence of our product
portfolio, and the invention and application of new technologies
across our three global business units of Orthopaedics,
Advanced Wound Management and Sports Medicine & ENT.
Founded in Hull, UK, in 1856, we now
operate in more than 100 countries, and generated annual sales of
$5.2 billion in 2022. Smith+Nephew is a constituent of the FTSE100
(LSE:SN, NYSE:SNN). The terms 'Group' and 'Smith+Nephew' are used
to refer to Smith & Nephew plc and its consolidated
subsidiaries, unless the context requires otherwise.
For more information about
Smith+Nephew, please visit www.smith-nephew.com and
follow us on X, LinkedIn, Instagram or Facebook.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
BOAZBLFLZLLLBBD
Smith & Nephew (LSE:SN.)
Historical Stock Chart
From Apr 2024 to May 2024
Smith & Nephew (LSE:SN.)
Historical Stock Chart
From May 2023 to May 2024